SCHEMBL3909700

SCHEMBL3909700

O=CCC[CH]c1ccccn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
KMT2A Q03164 2/20 0.52
ATM Q13315 1/20 0.52
NR4A1 P22736 1/20 0.41
NFE2L2 Q16236 2/20 0.40
MAOA P21397 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
IKBKB O14920 2/20 0.40
RAF1 P04049 2/20 0.40
RPS6KB1 P23443 2/20 0.40
MAPK1 P28482 2/20 0.40
AKT1 P31749 2/20 0.40
AKT2 P31751 2/20 0.40
KDR P35968 2/20 0.40
MAPKAPK2 P49137 2/20 0.40
PRKAG1 P54619 2/20 0.40
MAP2K1 Q02750 2/20 0.40
PRKAA1 Q13131 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL454528 0.78 MEN1 (0.54) MEN1NPC1RAB9AKMT2AATM
SCHEMBL96245 0.78 MEN1 (0.54) MEN1NPC1RAB9AKMT2AATM
SCHEMBL29950542 0.76 NPC1 (0.52) MEN1NPC1RAB9AKMT2AATM
SCHEMBL6245972 0.76 ALDH1A1 (0.47) MEN1NPC1RAB9AKMT2AATM
SCHEMBL498505 0.74 NPC1 (0.50) MEN1NPC1RAB9AKMT2AATM
SCHEMBL8552227 0.74 HRH1 (0.52) MEN1NPC1RAB9AKMT2AATM
SCHEMBL946754 0.74 NPC1 (0.50) MEN1NPC1RAB9AKMT2AATM
SCHEMBL15618374 0.74 NPC1 (0.45) MEN1NPC1RAB9AKMT2AATM
SCHEMBL270008 0.74
SCHEMBL14312150 0.73 NPC1 (0.60) MEN1NPC1RAB9AKMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009010296-A2 ANTIBODIES AGAINST 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE AND METABOLITES THEREOF CENTRE DE RECHERCHE PUBLIQUE SANTÉ (LU) 2009-01-22 WO claimed
EP-2016954-A1 Antibodies against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites thereof Muller, Claude P. (LU) 2009-01-21 EP claimed
CN-105241991-B Analysis method capable of simultaneously splitting characteristic nitrosamine chiral molecules of tobacco 贵州省烟草科学研究院 2017-04-19 CN disclosed
WO-2009010296-A3 ANTIBODIES AGAINST 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE AND METABOLITES THEREOF CT DE RECH PUBLIQUE SANTE (LU) 2009-06-18 WO disclosed
WO-2009010296-A2 ANTIBODIES AGAINST 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE AND METABOLITES THEREOF CENTRE DE RECHERCHE PUBLIQUE SANTÉ (LU) 2009-01-22 WO disclosed
WO-2009010296-A2 ANTIBODIES AGAINST 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE AND METABOLITES THEREOF CENTRE DE RECHERCHE PUBLIQUE SANTÉ (LU) 2009-01-22 WO disclosed
EP-2016954-A1 Antibodies against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites thereof Muller, Claude P. (LU) 2009-01-21 EP disclosed
EP-2016954-A1 Antibodies against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites thereof Muller, Claude P. (LU) 2009-01-21 EP disclosed
WO-2006009527-A1 TOBACCO-SPECIFIC NITROSAMINE DETECTION ASSAYS AND REAGENTS SWEDISH MATCH NORTH AMERICA, INC. (US) 2006-01-26 WO disclosed
US-20050043515-A1 Tobacco-specific nitrosamine detection assays and reagents SWEDISH MATCH NORTH AMERICA, INC. 2005-02-24 US disclosed